GKB Ophthalmics Share Price

Small Cap | Pharmaceuticals and health care | BSE: 533212

₹75.27 image1.71 (2.32 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 78.60

High (₹) 78.60

Low (₹) 73.03

Prev. Close (₹) 73.56

Volume 6,814

VWAP (₹) 80.77

ROCE (%) -1.19

Industry P/E 32.09

TTM P/E -8.60

P/B Ratio 0.59

Market Cap (₹) Cr.37.94

Dividend Yield (%)--

EPS (₹) -5.58

ROE-4.38%

Sales Growth (%) 16.93

Profit Growth (%)-3,618.05

Day Range

78.6078.60

L
H

52 Week Range

71.55136.40

L
H

Historical Returns

Returns (6M)

-34 %

Returns (1Y)

-5.3 %

Returns (3Y)

-16.87 %

Returns (5Y)

63.99 %

Returns (6M)

-34 %

Returns (1Y)

-5.3 %

Returns (3Y)

-16.87 %

Returns (5Y)

63.99 %

SWOT Analysis

  • Company with (1590.91%) TTM EPS Growth
  • Company with Low Debt
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 51.24

MFI 19.93

ATR 6.03

Commodity Channel Index -87.77

ROC125 -32.24

ROC21 -8.97

Williams %R -70.98

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current84.1687.0191.0480.1377.2873.2570.40
Week Ago84.4886.9888.9782.4979.9978.0075.50
Month Ago91.0592.3594.7588.6587.3584.9583.65

EMA & SMA
info_icon

75.27

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 81.38


9 Day 80.82


10 Day 81.59


12 Day 83.81


14 Day 85.06

20 Day 87.71


26 Day 87.81


50 Day 92.29


100 Day 96.96


200 Day 102.02

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
BRIJENDRA KUMAR GUPTAbulkSell10 Dec, 2024₹103.6837,625BSE
RAGINI CHETAN MEHTAbulkSell29 Apr, 2024₹132.75818BSE
COUNTER CYCLICAL INVESTMENTS PRIVATE LIMITEDbulkSell29 Apr, 2024₹136.4079,754BSE
RAGINI CHETAN MEHTAbulkBuy29 Apr, 2024₹135.8927,869BSE
AMIT KUMAR JAIN HUFbulkSell23 Apr, 2024₹117.3827,056BSE
AMIT KUMAR JAIN HUFbulkBuy23 Apr, 2024₹120.2617,056BSE
SANJIV KUMAR GUPTAbulkSell10 Apr, 2023₹113.9928,121BSE
AGARWAL KUMAR RAJbulkSell24 Jan, 2023₹173.7029,874BSE
AGARWAL KUMAR RAJbulkSell28 Dec, 2022₹103.8529,000BSE
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDbulkBuy28 Dec, 2022₹103.6333,419BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
31 Dec, 2024Krishna Gopal Gupta & Sons HUFAcquisition₹99.30249BSE
31 Dec, 2024Krishna Gopal Gupta & Sons HUFAcquisition₹101.12100BSE
31 Dec, 2024Krishna Gopal Gupta & Sons HUFAcquisition₹100.4850BSE
31 Dec, 2024Krishna Gopal GuptaAcquisition₹100.23500BSE
31 Dec, 2024Krishna Gopal Gupta & Sons HUFAcquisition₹101.14621BSE
31 Dec, 2024Krishna Gopal Gupta & Sons HUFAcquisition₹99.67330BSE
20 Jun, 2024Gurudas Krishna SawantAcquisition₹94.91425BSE
30 Mar, 2024Krishna Gopal GuptaAcquisition₹88.261,900BSE
30 Mar, 2024Krishna Gopal Gupta & SonsHUFAcquisition₹90.58418BSE
30 Mar, 2024Krishna Gopal Gupta & SonsHUFAcquisition₹86.2520BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
13 Feb, 2025BSE IndiaPursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE circular no. 20250102-4 dated January 02, 2025, please find enclosed herewith Integrated filing (Financial) of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe above information will also be made available on the website of the Company at www.gkb.net.\r\n\r\nKindly take the above information on record.
13 Feb, 2025BSE IndiaPlease find enclosed the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.\r\n\r\nThe unaudited financial results and the limited review reports are available on the company''s website www.gkb.net and the BSE website www.bseindia.com
13 Feb, 2025BSE IndiaThe meeting of the Board of Directors of the Company was held on February 13, 2025 which considered and took on record the unaudited standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe above unaudited financial results and the limited review reports are available on the Company''s Website www.gkb.net and on BSE website www.bseindia.com.\r\n\r\nThe Board of Director''s meeting started at 4:15 P.M. and ended at 4:55 P.M. , on the same day.\r\n\r\nKindly take the information on record.
06 Feb, 2025BSE IndiaPursuant to Regulation 27(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 read with SEBI Circular SEBI /HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 regarding Integrated Filing; please find attached the Integrated Corporate Governance Report for the quarter ended December 31, 2024 as per the format prescribed in the above mentioned SEBI Circular.\r\n\r\nPlease note that the said Corporate Governance Report has been filed in XBRL format as well, in addition to this Disclosure.\r\n\r\nKindly take the information on record.
24 Jan, 2025BSE IndiaGKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe Notice can be accessed at the Company''s Website at www.gkb.net\r\n\r\nFurther notices is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated person, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, which has been closed , will now re- open on Monday , February 17, 2025.\r\n\r\n
03 Jan, 2025BSE IndiaA meeting of the Board of Directors of the Company was held on January 03, 2025, which considered and approved the borrowing by way of an unsecured loan of upto Rs. 5.00 Crores ( Rupees Five Crores only) in tranches at rate of interest of 10.65% p.a. from GSV Ophthalmics Private Limited, a material subsidiary of the Company for the working capital requirements and general business purpose.\r\n\r\nFurther, the Board of Directors approved and executed the Loan Agreement on January 03, 2025 between the Company and GSV Ophthalmics Private Limited for an amount of upto Rs. 5.00 Crores to be availed by the Company in tranches.\r\n\r\nEnclosed please find the details of the Loan Agreement.\r\n\r\nThe meeting started at 11:35 A.M., and ended at 12.20 P.M. , on the same day.\r\n\r\nKindly take the information on record.\r\n\r\n
02 Jan, 2025BSE IndiaThis is to inform you that the material subsidiary of the Company, GSV Ophthalmics Private Limited in its Board Meeting held on December 30, 2024 and Extra Ordinary General Meeting with shorter notice held today, January 02, 2025 has approved to grant an unsecured loan of upto Rs. 5.00 Crores ( Rupees Five Crores Only) in tranches to GKB Ophthalmics Limited for the purpose of working capital requirements and general business purpose of the Company.\r\n\r\nThe Board meeting of GKB Ophthalmics Limited for consideration and approval of loan sanctioned by the Subsidiary Company, GSV Ophthalmics Private Limited will be held on Friday, January 03, 2025.\r\n\r\nKindly take the information on record.
14 Nov, 2024BSE IndiaPursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a disclosure on Related Party Transaction on Consolidated basis for the half year ended September 30, 2024.\r\n\r\nKindly take the information on record.\r\n
14 Nov, 2024BSE IndiaThe Board of Directors in the meeting held on November 14, 2024 considered and took on record the Unaudited Standalone and Consolidate Financial Results for the quarter and half year ended September 30, 2024.\r\n\r\nKindly take information on record.
14 Nov, 2024BSE IndiaThe meeting of the Board of Directors of the company was held on November 14, 2024, which considered and took on record the Unaudited standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024.\r\n\r\nThe above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com.\r\n\r\nThe Board of Directors'' Meeting started at 04.15 P. M and ended at 05.05 P.M, on the same day.\r\n\r\nKindly take the information on record.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--25 Jan, 202513 Feb, 2025
Quarterly Results--31 Oct, 202414 Nov, 2024
Quarterly Results--22 Jul, 202413 Aug, 2024
Audited Results--26 Apr, 202430 May, 2024
Quarterly Results--31 Jan, 202414 Feb, 2024
Quarterly Results--31 Oct, 202314 Nov, 2023
Quarterly Results--28 Jul, 202311 Aug, 2023
Audited Results--15 May, 202330 May, 2023
Quarterly Results--01 Feb, 202314 Feb, 2023
Quarterly Results--29 Jul, 202212 Aug, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameSept, 2024Jun, 2024Mar, 2024Dec, 2023Sept, 2023

About GKB Ophthalmics

GKB Ophthalmics is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company’s Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469. Currently Company is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company’s Total Operating Revenue is Rs. 31.18 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1981

Managing Director

Mr. K G Gupta

NSE Symbol

--

GKB Ophthalmics Management

NameDesignation
Mr. K G GuptaChairman & Managing Director
Mr. Vikram GuptaDirector
Mrs. Shashi Kumar KatreddiDirector
Mr. Purushottam S MantriDirector
Mrs. Sandhya Ajit KamatDirector

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Yash Optics & Lens₹180.42₹72.85 image
₹77.70(-6.24%)
₹72.600 - ₹121.850
Kretto Syscon₹117.28₹1.87 image
₹1.91(-2.09%)
₹0.930 - ₹1.950
GKB Ophthalmics₹37.94₹75.27 image
₹73.56(2.32%)
₹71.550 - ₹136.400

FAQs on GKB Ophthalmics

What is the share price of GKB Ophthalmics?

The share price of GKB Ophthalmics on 13 Mar, 2025 is ₹ 75.27.

What is 52W high and 52W low share price of GKB Ophthalmics?

The highest and lowest 52W share prices of GKB Ophthalmics are ₹ 136.400 and ₹ 71.550

What is the market cap of GKB Ophthalmics?

The market capitalization of GKB Ophthalmics as of 13 Mar, 2025 is ₹ 37.94 Crores

What is the P/E ratio of GKB Ophthalmics?

The current P/E ratio of GKB Ophthalmics as of 13 Mar, 2025 is 32.09

What is the PB ratio of GKB Ophthalmics?

The PB ratio of GKB Ophthalmics as of 13 Mar, 2025 is 0.59

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited